Replies to post #13903 on Aurinia Pharmaceuticals Inc (AUPH)

[nsomniyak]

That is my assumption as well. Any BP that has even a glimmer of interest in the drug has already seen the data and is under NDA. None of those big companies woke up last Friday and said "Hey, maybe we should look into AUPH".

[Whalatane]

Micham. You are / were a practicing attorney … correct ?
And you think AUPH has shared the AURORA -2 data already , to whom they deem interested BP’s under Non Disclosure Agreements ?
And Co faces no legal jeopardy in doing so ?
Safest thing for AUPH is to announce / publish this trials results all at once to all .
Top line data first followed by details in a publication like the NEJM / Lancet if necessary

There are signals from an earlier trial that Voclosporin may slightly improve eGFR …which would be huge as these patients are expected to have declining kidney function over time
This trial will also , I think ,have the longest safety data of any drug used for LN
They won’t rush the analysis and will chk and rechk their data , slice and dice it ( who benefits most and why ) before publishing / sharing
JMO
Kiwi